Completed NA INTERVENTIONAL 2-arm NCT02248948

Superiority of Omega-3 Versus Placebo on the Improvement of ADHD in Children (ECOMEGA)

Multicenter Randomized Controlled Trial for the Evaluation of Superiority of a Supplement With Omega-3 Fatty Acids Versus Placebo for the Improvement of Attention Deficit and Hyperactivity Disorder (ADHD) in Children

Sponsor: Clever Instruments S.L.

Conditions Attention Deficit Hyperactivity Disorder (ADHD)

Interventions Medium Chain Triglycerides Omega-3 Fatty Acids

Updated 6 times since 2017 Last updated: Jul 17, 2019 Started: Sep 30, 2014 Primary completion: Jul 31, 2016 Completion: Jul 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Attention Deficit Hyperactivity Disorder (ADHD), this trial is completed. The trial is conducted by Clever Instruments S.L. and has accumulated 6 data snapshots since 2014. Psychiatric clinical trials are essential for establishing evidence-based treatment standards.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Aug 2019 — Jan 2021 [monthly]

Completed NA

Phase: PHASE4 → NA
Jun 2018 — Aug 2019 [monthly]

Completed PHASE4

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Sep 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Clever Instruments S.L.
Laboratorios Ordesa

Data source: Laboratorios Ordesa

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Barcelona, Spain